Natalizumab is highly effective disease modifying agent for relapsing remitting multiple sclerosis. However, it’s associated with increased risk of progressive multifocal leukoencephalopathy (PML) caused by John Cunningham virus (JC virus)....

Full Text

Published Version
Open DOI Link

Get access to 250M+ research papers

Discover from 40M+ Open access, 3M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call